Fridays tirzepatide: price, structure, and position (2026)

Fridays charges $359 a month all-in for compounded tirzepatide at the 10 mg maintenance basis — dose-flat across the entire ladder, with no membership fee — ranking #13 of 17 verified programs (captured 2026-08-05).

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

THIRD-PARTY REPORTED · captured 2026-08-05

§ The tirzepatide record, in words

What Fridays bills for tirzepatide, exactly

Fridays’s tirzepatide program bills $359 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Fridays is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

There is no membership line. $359 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #13 of 17 in the verified tirzepatide index — $144/month above the floor (NexLife↗, $215) — and sits $90 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $4,308.

Tirzepatide, across time

Multiplying the all-in figure across real horizons — the fastest honesty test in this category:

1 month: $359 billed monthly. 3 months: $1,077 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 6 months: $2,154 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 9 months: $3,231 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 12 months: $4,308 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 18 months: $6,462 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 24 months: $8,616 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path.

Remember what the arithmetic cannot know: whether you will tolerate the medication, whether the dose will move (financially irrelevant here, since pricing is flat), and whether the program’s terms will hold. The calculator reruns all of this at your inputs.

Where this price sits — tirzepatide

In the tirzepatide index, Fridays ranks #13 of 17 verified programs — $144 a month above the floor (NexLife, $215) and $238 under the ceiling (LifeMD↗, $597). One rung cheaper sits Lavender Sky Health↗ at $352 — a $7 monthly gap, $84 across a year — Lavender Sky Health’s full record is one click away on its provider page. One rung pricier is MEDVi↗ at $399 (+$40/month); that comparison lives at Fridays vs MEDVi. Against the approved product: Zepbound (LillyDirect) runs $449 at maintenance, so Fridays is $90 a month ($1,080/year) under brand; note the maintenance figure holds only with refills inside Lilly’s 45-day window.

Against the five nearest rivals — tirzepatide

Lavender Sky Health costs $7 less a month ($84/year) at $352 ($25/mo membership inside its figure, tiered/step structure). Henry Meds costs $10 less a month ($120/year) at $349 (no membership, dose-flat). TrimRx costs $10 less a month ($120/year) at $349 (no membership, dose-flat). MEDVi costs $40 more a month ($480/year) at $399 (no membership, dose-flat). Remedy Meds costs $40 more a month ($480/year) at $399 (no membership, dose-flat).

Operationally: Shipping is included, so the door-to-door figure is the advertised figure; the clinical consultation is included rather than billed separately; labs are not required to enroll (a prescriber can still order them for cause, which is medicine, not upsell). Commitment: annual plan for lowest rate; cancellation: not published. Fulfillment is the weak point of the record: the pharmacy is not publicly named beyond “not named”, so the license-checking a careful buyer would do is not possible from the outside. Ask during intake, in writing, before paying.

Where these numbers come from: third-party reported, last read 2026-08-05 from the provider’s published pages. Every figure above traces to a dated capture; when the provider’s page changes, the database changes, and the diff lands in the changelog. If any number here no longer matches what Fridays publishes, tell the desk — confirmed errors are fixed sitewide in one rebuild and logged permanently.

§ Adjacent pages